These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28965256)

  • 1. Effects of rosuvastatin and atorvastatin on nonsustained ventricular tachycardia in patients with ST-elevation myocardial infarction: a retrospective analysis.
    Hu X; Cheng J; Li C
    Eur J Clin Pharmacol; 2018 Jan; 74(1):29-35. PubMed ID: 28965256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Dai Y; Huang J; Zeng L; Huang Z; Duan C; Shao S; Chen H; Xue L; Chen J; Tan N; He P; Liu Y; Yu D
    Biomed Pharmacother; 2020 Aug; 128():110336. PubMed ID: 32521452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The impact of different doses of atorvastatin on plasma endothelin and platelet function in acute ST-segment elevation myocardial infarction after emergency percutaneous coronary intervention].
    Xu XR; Li KB; Wang P; Xu L; Liu Y; Yang ZS; Yang XC
    Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):932-936. PubMed ID: 27916047
    [No Abstract]   [Full Text] [Related]  

  • 4. Elevated T-wave alternans predicts nonsustained ventricular tachycardia in association with percutaneous coronary intervention in ST-segment elevation myocardial infarction (STEMI) patients.
    Verrier RL; Nearing BD; Ghanem RN; Olson RE; Garberich RF; Katsiyiannis WT; Gornick CC; Tang CY; Henry TD
    J Cardiovasc Electrophysiol; 2013 Jun; 24(6):658-63. PubMed ID: 23445517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of atorvastatin and rosuvastatin on dysfunctional coronary circulation in patients with ST-segment elevation myocardial infarction.
    Zhou L; Hu X; Zhang H; Lu H; Lin Y; Wang W; Yu B; Liang W; Zhou Y; Li G; Dong H
    J Int Med Res; 2023 Jun; 51(6):3000605231182547. PubMed ID: 37377087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosuvastatin versus atorvastatin to prevent contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA-cIN trial).
    Kaya A; Kurt M; Tanboğa IH; Işik T; Ekinci M; Aksakal E; Kaya Y; Topçu S; Sevimli S
    Acta Cardiol; 2013 Oct; 68(5):489-94. PubMed ID: 24283110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
    Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
    Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a hydrophilic and a hydrophobic statin on cardiac salvage after ST-elevated acute myocardial infarction - a pilot study.
    Chitose T; Sugiyama S; Sakamoto K; Shimomura H; Yamashita T; Hokamaki J; Tsunoda R; Shiraishi S; Yamashita Y; Ogawa H
    Atherosclerosis; 2014 Nov; 237(1):251-8. PubMed ID: 25262434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of early and intensive statin therapy on ventricular premature beat or nonsustained ventricular tachycardia in patients with acute coronary syndrome.
    He XZ; Zhou SH; Wan XH; Wang HY; Zhong QH; Xue JF
    Clin Cardiol; 2011 Jan; 34(1):59-63. PubMed ID: 21259280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence.
    Borovac JA; Leth-Olsen M; Kumric M; D'Amario D; Schwarz K; Glavas D; Bozic J
    Eur J Clin Pharmacol; 2022 Jan; 78(1):111-126. PubMed ID: 34423376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial.
    Briguori C; Madonna R; Zimarino M; Calabrò P; Quintavalle C; Salomone M; Condorelli G; De Caterina R
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):465-472. PubMed ID: 27358173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study.
    Liu HL; Yang Y; Yang SL; Luo JP; Li H; Jing LM; Shen ZQ
    Clin Ther; 2013 Mar; 35(3):261-72. PubMed ID: 23410871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcomes in Survivors of Early Ventricular Arrhythmias After Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention.
    Liang JJ; Fender EA; Cha YM; Lennon RJ; Prasad A; Barsness GW
    Am J Cardiol; 2016 Mar; 117(5):709-13. PubMed ID: 26796195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of different doses of atorvastatin, rosuvastatin, and simvastatin on elderly patients with ST-elevation acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI).
    He W; Cao M; Li Z
    Drug Dev Res; 2020 Aug; 81(5):551-556. PubMed ID: 32142170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of high-dose atorvastatin and high-dose rosuvastatin on oxidative stress in patients with acute myocardial infarction: A pilot study.
    Kilit C; Koçak FE; Paşalı Kilit T
    Turk Kardiyol Dern Ars; 2017 Apr; 45(3):235-243. PubMed ID: 28429691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Trends, Effectiveness, and Safety of Statins on Lipid Goal Attainment in Chinese Percutaneous Coronary Intervention Patients: a Multicenter, Retrospective Cohort Study.
    Chen Y; Li D; Jing J; Yan H; Liu J; Shen Z; James S; Varenhorst C
    Clin Ther; 2017 Sep; 39(9):1827-1839.e1. PubMed ID: 28807393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India.
    Roy D; Mahapatra T; Manna K; Kar A; Rana MS; Roy A; Bose PK; Banerjee B; Paul S; Chakraborty S
    PLoS One; 2020; 15(5):e0233230. PubMed ID: 32428019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do statins influence the prognostic impact of non-sustained ventricular tachycardia after ST-elevation myocardial infarction?
    Lorenz H; Jünger C; Seidl K; Gitt A; Schneider S; Schiele R; Wienbergen H; Winkler R; Gottwik M; Delius W; Senges J; Rauch B
    Eur Heart J; 2005 Jun; 26(11):1078-85. PubMed ID: 15728647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Treatment Efficacy of Rosuvastatin versus Atorvastatin Loading Prior to Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction.
    Adel EM; Elberry AA; Abdel Aziz A; Naguib IA; Alghamdi BS; Hussein RRS
    J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36079090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
    Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
    JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.